Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate and evaluate the effects of different
interventions (1. exenatide, 2. insulin, 3. thiazolidinedione) on glycemic control and β-cell
function in newly diagnosed drug-naïve type 2 diabetic patients.
Phase:
N/A
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Amylin Pharmaceuticals, LLC. Eli Lilly and Company Ministry of Health, China